About this episode
Dillan DiNardo is the Co-Founder and CEO of Mindstate Design Labs - A Y Combinator-incubated psychedelic drug development company designing altered states of consciousness for mental health therapeutics.Dillan joins us today to talk about his journey to the forefront of the psychedelic drug development space, as well as to provide insight on the immense arena of untapped potential that exists within lesser known classes of various molecules synthesized by the likes of legendary chemist Sasha Shulgin and much more.
Please rate and review this podcast wherever you're listening.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur
Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur
Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur
Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur
Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur